Digital health

  • Eleven NHS sites adopt new physiotherapy platform Phio to cut service wait times

    Eleven NHS organisations – including three Primary Care Networks (PCNs) – have now gone live with, or signed contracts to deploy Phio, a musculoskeletal (MSK) triage and rehabilitation technology, giving an estimated 2.3 million registered patients the option to start physio care instantly on their phone instead of waiting for a GP appointment. The drive [...]

  • The NHS efficiency dilemma: Is AI really the solution?

    By Peter Corpe, Industry Leader, UK Public Sector, Appian Despite the Government’s commitment to ‘bring the NHS into the digital age’ in its AI Opportunities Action Plan healthcare organisations still rely on legacy systems that aren’t fit for purpose. And the State of digital government review from the Department for Science, Innovation and Technology (DSIT) [...]

  • Medway NHS Foundation Trust powers virtual hospital vision with seamless tech transition

    Medway NHS Foundation Trust has taken a bold step forward in  its virtual care journey by transitioning to a new digital platform - part of its strategy to  scale a full virtual hospital at the heart of an integrated neighbourhood. Partnering with  health tech provider Feebris, the Trust has not only ensured continuity of care [...]

  • NHS App to offer clinical trial access in major digital health update

    NHS App users will soon be able to browse and sign up for clinical trials, under government plans to speed up research and widen access to new treatments. The new feature will eventually use artificial intelligence to match people to relevant studies based on their health records and interests, with alerts sent when suitable trials [...]

  • Better Meds and BD partner to advance medication management

    Better Meds and BD have partnered to integrate BD Pyxis automated dispensing cabinets (ADC) with Better Meds’ electronic prescribing and medicines administration (ePMA) system, ensuring safer and more efficient medication administration than manual processes on hospital wards in collaboration with University Hospitals Plymouth NHS Trust. Hospitals increasingly rely on ePMA systems like Better Meds to [...]

  • CardMedic secures £411,000 Innovate UK grant to transform healthcare communication barriers

    CardMedic, the frontline healthcare language app, has secured £411,000 in funding from Innovate UK's SMART grant programme. The grant will fund a 12-month project, running from April 2025 to March 2026, to scale and integrate an innovative portal transforming how healthcare organisations deliver language services. CardMedic will strengthen its existing solution to create a seamless, [...]

  • NHS England first in the world to roll out ‘trojan horse’ therapy for blood cancer

    The NHS in England will be the first health system globally to offer a ‘trojan horse’ targeted treatment for blood cancer that could delay disease progression nearly three times longer than current options. Belantamab mafodotin will be made available to around 1,500 patients a year with multiple myeloma – an incurable cancer of the bone [...]

  • Highland Marketing announced as official communications partner for HETT 2025

    Highland Marketing has been named, for the second year running, the official communications partner for HETT Show 2025, the UK’s leading digital health conference and exhibition. Taking place 7–8 October 2025 at ExCeL London, HETT will welcome thousands of healthcare professionals, policy makers, and technology leaders for two days of insights, collaboration, and sector-shaping conversations. [...]

  • Virtual cancer clinic Perci Health raises £3m

    Digital cancer care provider Perci Health has raised £3m in a funding round that exceeded its initial £1.5m goal, bringing its total raised to £7.7m to date, as it looks to expand partnerships with employers and insurers. The company offers AI-powered support for cancer patients via a digital platform, combining technology with input from nurses, [...]

  • Mosanna Therapeutics raises US$80m to develop nasal spray for sleep apnoea

    Mosanna Therapeutics has secured US$80m in Series A funding to advance development of a nasal spray for obstructive sleep apnoea (OSA), a condition where breathing stops and starts during sleep due to a blocked airway. The investment will support Phase II trials of MOS118, a spray used at night which aims to restore natural airway [...]